69 research outputs found
Large Genomic Imbalances in Brugada Syndrome
Purpose Brugada syndrome (BrS) is a form of cardiac arrhythmia which may lead to sudden cardiac death. The recommended genetic testing (direct sequencing of SCN5A) uncovers disease-causing SNVs and/or indels in ~20% of cases. Limited information exists about the frequency of copy number variants (CNVs) in SCN5A in BrS patients, and the role of CNVs in BrS-minor genes is a completely unexplored field. Methods 220 BrS patients with negative genetic results were studied to detect CNVs in SCN5A. 63 cases were also screened for CNVs in BrS-minor genes. Studies were performed by Multiplex ligation-dependent probe amplification or Next-Generation Sequencing (NGS). Results The detection rate for CNVs in SCN5A was 0.45% (1/220). The detected imbalance consisted of a duplication from exon 15 to exon 28, and could potentially explain the BrS phenotype. No CNVs were found in BrS-minor genes. Conclusion CNVs in current BrS-related genes are uncommon among BrS patients. However, as these rearrangements may underlie a portion of cases and they undergo unnoticed by traditional sequencing, an appealing alternative to conventional studies in these patients could be targeted NGS, including in a single experiment the study of SNVs, indels and CNVs in all the known BrS-related genes
Basal ganglia volume predicts speed processing performance in obese adolescents
La obesidad se ha relacionado con cambios estructurales en los ganglios basales y alteraciones en dominios transversales como la velocidad de procesamiento. El objetivo del presente estudio es investigar la relación entre velocidad de procesamiento y volumen de los ganglios basales en adolescentes con y sin obesidad. Treinta y tres participantes obesos y treinta y tres con peso normal fueron resonados (Siemens 3T Trio) y evaluados neuropsicológicamente. Se compararon los resultados de un índice de velocidad y la ratio de los ganglios basales controlando por edad, sexo y tamaño de la cabeza. Se realizaron regresiones lineales con las estructuras relacionadas con este índice. Se encontraron diferencias en el índice de velocidad, pero no en la ratio de los ganglios basales. El grupo con obesidad mostró una correlación positiva entre velocidad y ratio del globo pálido derecho (r= .41; p= .021). No hallamos relaciones significativas en el grupo normopeso. La ratio del globo pálido derecho predijo parte del rendimiento en velocidad en adolescentes obesos. Las diferencias en velocidad de procesamiento entre adolescentes con y sin obesidad podrían estar moderadas por el tamaño de estructuras subcorticales como el globo pálido.Obesity is related to structural changes in basal ganglia and alterations among transversal domains such as speed processing. The aim of the study is to address the relationship between speed processing and basal ganglia volumes in adolescents with and without obesity. Thirty-three obese and 33 normal-weight participants underwent MRI acquisition (Siemens 3T Trio) and neuropsychological assessment to obtain an index of speed processing. Speed processing index and basal ganglia ratios (VolBrain software) were compared controlling for age, sex and head size. Linear regressions were conducted in the structures related to such index. Groups differed for speed processing index, but did not differ for basal ganglia ratios. The obese group showed positive correlations between speed processing index and the right globus pallidum ratio (r= .41; p= .021). None relationship was found among normal-weight adolescents. Concretely, the right globus pallidum ratio predicted part of the performance in speed in obese participants. The differences in speed processing between adolescents with and without obesity might be mediated by the size of subcortical structures such as the globus pallidum
Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism
Glutaminase is expressed in most mammalian tissues and cancer cells, but the regulation of its expression is poorly understood. An essential step to accomplish this goal is the characterization of its species- and cell-specific isoenzyme pattern of expression. Our aim was to identify and characterize transcript variants of the mammalian glutaminase Gls2 gene.We demonstrate for the first time simultaneous expression of two transcript variants from the Gls2 gene in human, rat and mouse. A combination of RT-PCR, primer-extension analysis, bioinformatics, real-time PCR, in vitro transcription and translation and immunoblot analysis was applied to investigate GLS2 transcripts in mammalian tissues. Short (LGA) and long (GAB) transcript forms were isolated in brain and liver tissue of human, rat and mouse. The short LGA transcript arises by a combination of two mechanisms of transcriptional modulation: alternative transcription initiation and alternative promoter. The LGA variant contains both the transcription start site (TSS) and the alternative promoter in the first intron of the Gls2 gene. The full human LGA transcript has two in-frame ATGs in the first exon, which are missing in orthologous rat and mouse transcripts. In vitro transcription and translation of human LGA yielded two polypeptides of the predicted size, but only the canonical full-length protein displayed catalytic activity. Relative abundance of GAB and LGA transcripts showed marked variations depending on species and tissues analyzed.This is the first report demonstrating expression of alternative transcripts of the mammalian Gls2 gene. Transcriptional mechanisms giving rise to GLS2 variants and isolation of novel GLS2 transcripts in human, rat and mouse are presented. Results were also confirmed at the protein level, where catalytic activity was demonstrated for the human LGA protein. Relative abundance of GAB and LGA transcripts was species- and tissue-specific providing evidence of a differential regulation of GLS2 transcripts in mammals
Lipid Peroxidative Damage on Cisplatin Exposure and Alterations in Antioxidant Defense System in Rat Kidneys: A Possible Protective Effect of Selenium
Cisplatin (Cis-diamminedichloroplatinum II, CP) is an important chemotherapeutic agent, useful in the treatment of several cancers, but with several side effects such as nephrotoxicity. The present study investigated the possible protective effect of selenium (Se) against CP-induced oxidative stress in the rat kidneys. Male Wistar albino rats were injected with a single dose of cisplatin (7 mg CP/kg b.m., i.p.) and selenium (6 mg Se/kg b.m, as Na2SeO3, i.p.), alone or in combination. The obtained results showed that CP increased lipid peroxidation (LPO) and decreased reduced glutathione (GSH) concentrations, suggesting the CP-induced oxidative stress, while Se treatment reversed this change to control values. Acute intoxication of rats with CP was followed by statistically significant decreased activity of antioxidant defense enzymes: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR) and glutathione-S-transferase (GST). Treatment with Se reversed CP-induced alterations of antioxidant defense enzyme activities and significantly prevented the CP-induced kidney damage
Cerium Oxide Nanoparticles Protect Cardiac Progenitor Cells from Oxidative Stress
Cardiac progenitor cells (CPCs) are a promising autologous source of cells for cardiac
regenerative medicine. However, CPC culture in vitro requires the presence of microenvironmental
conditions (a complex array of bioactive substance concentration, mechanostructural
factors, and physicochemical factors) closely mimicking the natural cell surrounding in vivo,
including the capability to uphold reactive oxygen species (ROS) within physiological levels
in vitro. Cerium oxide nanoparticles (nanoceria) are redox-active and could represent a potent
tool to control the oxidative stress in isolated CPCs. Here, we report that 24 h exposure to 5, 10,
and 50 !g/mL of nanoceria did not a!ect cell growth and function in cardiac progenitor cells,
while being able to protect CPCs from H2O2-induced cytotoxicity for at least 7 days, indicating
that nanoceria in an e!ective antioxidant. Therefore, these "ndings con"rm the great
potential of nanoceria for controlling ROS-induced cell damage
Vitamin C Enhances Vitamin E Status and Reduces Oxidative Stress Indicators in Sea Bass Larvae Fed High DHA Microdiets
Docosahexaenoic acid (DHA) is an essential fatty acid necessary for many biochemical, cellular and physiological functions in fish. However, high dietary levels of DHA increase free radical injury in sea bass (Dicentrarchus labrax) larvae muscle, even when vitamin E (α-tocopherol, α-TOH) is increased. Therefore, the inclusion of other nutrients with complementary antioxidant functions, such as vitamin C (ascorbic acid, vitC), could further contribute to prevent these lesions. The objective of the present study was to determine the effect of vitC inclusion (3,600 mg/kg) in high DHA (5 % DW) and α-TOH (3,000 mg/kg) microdiets (diets 5/3,000 and 5/3,000 + vitC) in comparison to a control diet (1 % DHA DW and 1,500 mg/kg of α-TOH; diet 1/1,500) on sea bass larvae growth, survival, whole body biochemical composition and thiobarbituric acid reactive substances (TBARS) content, muscle morphology, skeletal deformities and antioxidant enzymes, insulin-like growth factors (IGFs) and myosin expression (MyHC). Larvae fed diet 1/1,500 showed the best performance in terms of total length, incidence of muscular lesions and ossification degree. IGFs gene expression was elevated in 5/3,000 diet larvae, suggesting an increased muscle mitogenesis that was confirmed by the increase in the mRNA copies of MyHC. vitC effectively controlled oxidative damages in muscle, increased α-TOH larval contents and reduced TBARS content and the occurrence of skull deformities. The results of the present study showed the antioxidant synergism between vitamins E and C when high contents of DHA are included in sea bass larvae diets
Pyruvate: immunonutritional effects on neutrophil intracellular amino or alpha-keto acid profiles and reactive oxygen species production
For the first time the immunonutritional role of pyruvate on neutrophils (PMN), free α-keto and amino acid profiles, important reactive oxygen species (ROS) produced [superoxide anion (O2−), hydrogen peroxide (H2O2)] as well as released myeloperoxidase (MPO) acitivity has been investigated. Exogenous pyruvate significantly increased PMN pyruvate, α-ketoglutarate, asparagine, glutamine, aspartate, glutamate, arginine, citrulline, alanine, glycine and serine in a dose as well as duration of exposure dependent manner. Moreover, increases in O2− formation, H2O2-generation and MPO acitivity in parallel with intracellular pyruvate changes have also been detected. Regarding the interesting findings presented here we believe, that pyruvate fulfils considerably the criteria for a potent immunonutritional molecule in the regulation of the PMN dynamic α-keto and amino acid pools. Moreover it also plays an important role in parallel modulation of the granulocyte-dependent innate immune regulation. Although further research is necessary to clarify pyruvate’s sole therapeutical role in critically ill patients’ immunonutrition, the first scientific successes seem to be very promising
Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells
When the tide is low. Intertidal archaeology in the estuaries of the province of Bizkaia (Basque Country, Spain)
Polyamine metabolism regulation by histamine and other biogenic amines in Ehrlich carcinoma cells
- …